These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16925506)
1. Sildenafil for pulmonary arterial hypertension: when blue turns into white. Antoniu SA Expert Opin Pharmacother; 2006 Sep; 7(13):1801-10. PubMed ID: 16925506 [TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension. Leibovitch L; Matok I; Paret G Drugs; 2007; 67(1):57-73. PubMed ID: 17209664 [TBL] [Abstract][Full Text] [Related]
4. Sildenafil: a review of its use in pulmonary arterial hypertension. Croom KF; Curran MP Drugs; 2008; 68(3):383-97. PubMed ID: 18257613 [TBL] [Abstract][Full Text] [Related]
5. Clinical use of sildenafil in pulmonary artery hypertension. Singh TP Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288 [TBL] [Abstract][Full Text] [Related]
6. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181 [TBL] [Abstract][Full Text] [Related]
7. Sildenafil in the treatment of pulmonary hypertension. Barnett CF; Machado RF Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension. Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil for pulmonary hypertension: need for evidence generation. Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698 [TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not. Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373 [TBL] [Abstract][Full Text] [Related]
11. New insights in the treatment strategy for pulmonary arterial hypertension. Sahara M; Takahashi T; Imai Y; Nakajima T; Yao A; Morita T; Hirata Y; Nagai R Cardiovasc Drugs Ther; 2006 Oct; 20(5):377-86. PubMed ID: 17124557 [TBL] [Abstract][Full Text] [Related]
12. Sildenafil for the treatment of pulmonary hypertension in children. Beghetti M; Wacker Bou Puigdefabregas J; Merali S Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406 [TBL] [Abstract][Full Text] [Related]
13. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension. Ramani GV; Park MH Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962 [TBL] [Abstract][Full Text] [Related]
14. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension. Pinto LM; Morekar S; Mahashur AA Indian J Chest Dis Allied Sci; 2009; 51(4):249-51. PubMed ID: 20073379 [TBL] [Abstract][Full Text] [Related]